Medication info
Apeco Tablet 10 mg (Atorvastatin Calcium Hydrate)

Apeco Tablet 10 mg (Atorvastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Hydrate›10.845mg / 1 tablet
Manufacturer / importer
Kukje Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201300149 · Approved 2013.01.08 · Insurance code 643703590

Summary

Main use
Improvement of hyperlipidemia (including familial hyperlipidemia in children); prevention of cardiovascular diseases (including myocardial infarction)
Who takes it
Adults · Children
Adult dose
Patients receiving atorvastatin before and during treatment should follow a standard cholesterol-lowering diet. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when starting treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: Efficacy and safety in patients 70 years of age or older are generally similar to those in the usual adult patient population.
Child dose
10 ~ 17 years: The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine higher than 20 mg in pediatric patients).

Ingredients

Manufacturer
Kukje Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia (including familial hyperlipidemia in children); prevention of cardiovascular diseases (including myocardial infarction)

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • hyperlipidemia
  • hypercholesterolemia
  • dyslipidemia
  • dysbeta-lipoproteinemia
  • elevated serum triglycerides
View approved original text

This medication helps to reduce various risk factors associated with cardiovascular disease. In particular, it reduces the risk of myocardial infarction and stroke in adults with multiple risk factors and patients with type 2 diabetes. Additionally, it is effective in reducing the risk of non-fatal myocardial infarction, stroke, vascular interventions, and hospitalization for heart failure in patients with clinical evidence of heart disease. In hyperlipidemia patients, it lowers total cholesterol, LDL cholesterol, and triglyceride levels while raising HDL cholesterol levels, thereby supporting dietary therapy. It is particularly helpful in managing cholesterol levels effectively in patients with familial hypercholesterolemia and in pediatric patients. This medication is used for the reduction of cardiovascular disease risk and the improvement of dyslipidemia.

How to take

Adult dose

Patients receiving atorvastatin before and during treatment should follow a standard cholesterol-lowering diet. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when starting treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: Efficacy and safety in patients 70 years of age or older are generally similar to those in the usual adult patient population.

Child dose

10 ~ 17 years: The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine higher than 20 mg in pediatric patients).

Precautions

This medication may cause unusual symptoms in muscles, so if severe muscle pain or muscle weakness occurs, or if creatine kinase levels rise significantly, discontinue use immediately and consult a physician. Patients with liver function issues or active liver disease should not use this medication. Patients with muscle disorders or those who have previously experienced muscle-related side effects should use this medication cautiously and may require regular testing. Women who are pregnant, potentially pregnant, or nursing should not take this medication, and women of childbearing age should use adequate contraception while taking this medication. This medication may interact with certain antibiotics, antifungals, and antivirals, so if taking other medications, be sure to inform your doctor or pharmacist. Elderly patients or those with impaired kidney function are at increased risk for muscle-related side effects, so caution is needed when taking this medication. During treatment with this medication, regular liver function tests and muscle-related tests should be conducted, and it is important to inform healthcare providers of any adverse symptoms. Children, especially those under 10 years of age, should not use this medication, and for children over 10, long-term safety has not been adequately verified. There is no specific antidote for overdose, and treatment should be based on symptoms, requiring regular testing. This medication should be kept out of reach of children and should be stored in its original container to maintain quality.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinopharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 172 more
  • loss of appetite
  • constipation
  • abdominal distension
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngodynia
  • laryngodynia
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • taste disturbance
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications from rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorder
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reaction
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • blistering dermatitis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • elevated serum CK
  • positive leukocytes in urine
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • pancreatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test results
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcer
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcer
  • dysphagia
  • melena
  • gingival bleeding
  • dysgeusia
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory disturbance
  • peripheral neuropathy
  • vertigo
  • phototoxic reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinesia
  • depression
  • heightened tension
  • myositis
  • muscle disease
  • arthritis
  • bursitis
  • tenosynovitis
  • myasthenia gravis
  • tendon contracture
  • elevated serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcer
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast hypertrophy
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency in urination
  • abnormal ejaculation
  • uterine bleeding
  • colored urine
  • hypoglycemia
  • increased appetite
  • vasomotor edema
  • chest pain
  • angina pectoris
  • facial swelling
  • fever
  • cervical stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive error
  • ocular hemorrhage
  • hearing loss
  • glaucoma
  • dysgeusia
  • taste distortion
  • leukopenia
  • anemia
  • decreased testosterone
  • elevated cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • increased potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a sealed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature to safely preserve its efficacy.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.